Sanofi India Limited will hold a meeting of its Board of Directors on Thursday, October 29, 2026, to consider and approve the unaudited financial results for the quarter and nine-months ended September 30, 2026, and to consider, declare, and approve an interim dividend, if any, for the financial year 2026. The company also stated that the trading window will remain closed from October 1, 2026, until 48 hours after the announcement of the results to the Bombay Stock Exchange and the National Stock Exchange of India.